medic suppli devic
reason report
bottom line deliv anoth strong quarter
organ sale growth acceler
organ sale growth
note quarter strong organ growth number come
compani easiest y/i compar recent year still sens
expect organ sale growth quarter
perform -- coupl realli last quarter -- place
strongli top-tier med-tech handili exceed
consensu -- deliv clean oper quarter despit
as-expect oper margin compress y/i
bp sequenti -- expect share trade higher today
addit manag rais midpoint ep
guidanc rang -- ahead beat vs consensu
-- suggest perhap back half momentum remain posit
us execut stori compani integr
recent major acquisit drive new product cycl
medic devic busi sustain mid-to-high singl digit growth
across legaci busi double-digit growth establish
product epd quarter perform admittedli seem
posit data point support view success
call began edt dial-in pw
revenu ep vs street
estim deliv sale
nearli ahead us street report revenu
impact less favor fx impact strong organ growth
highlight continu top-lin growth momentum sale
organ vs
notabl quarter includ epd
deliv strong organ sale growth quarter still come
particularli easi y/i compar sale
organ due channel dynam associ implement
new good servic tax system india comp-adjust
epd growth probabl closer high-single-digit could rais
 extent turnaround possibl protract
weak russian channel dynam impact
intern pediatr nutrit post strongest organ growth
quarter sever year comp still rel
easi repres meaning acceler vs even
comp-adjust basi could signal well-posit
china nutrit market take advantag recently-impl
qualiti control regul diabet growth acceler quarter
put organ growth vs
particular strength vs
point -- surprisingli base -- still strong
libr launch cardiovascular neuromodul tick
bit quarter organ sale growth vs
pleas refer page import disclosur price chart analyst certif
-- sale growth deceler even meaning
comp-adjust basi -- could point protract
share shift see and/or support
hospit administr survey link point real meaning
pickup procedur volum vs perspect
quarter clean real impact non-oper
income/expens oper margin compress y/i
deliv posit leverag sequenti -- bp vs come
bp ahead us consensu
read-through devic player cardio diabet
neuromodul overal think cardiovascular
neuromodul perform support saw hospit
administr survey -- brought real season pickup volum
despit easi y/i compar us could suggest either
op benefit meaning launch full
suit mri-saf product vs and/or market may
taken step quarter perhap due price pressur
major player mri-saf product offer diabet
oper sale growth meaning step-up
clearli reflect continu
libr launch momentum attribut market expans
vs meaning market share grab vs op support
recent cgm continu glucos monitor survey link
ada check link neuromodul see sale growth
deceler meaning quarter specif
sale grew vs
comp-adjust growth deceler
dramat seem potenti signal either
slower market share gain -- possibl even market share loss --
posit player op op mp
and/or possibl slowdown spinal cord stimul
market volum growth seen recent quarter
would argu larg expect base comp
outlook move higher reflect out-performance
on-going momentum back half rais ep guidanc
vs us street
key put take guidanc view like
success integr aler impact key new product approv
notabl mri-saf icds/crt-d acquir acquisit
stj stem share loss busi freestyl libr
continu strength across legaci busi includ
diagnost nutrit epd
y/i
ww growth rate report
point
point
point
point
point
point
cardiovascular neuromodul
cardiovascular neuromodul
cardiovascular neuromodul
cardiovascular neuromodul
cardiovascular neuromodul
cardiovascular neuromodul
rapid diagnost reflect sale aler inc acquir oct compar oper
growth rate exclud result rapid diagnost busi
compar oper sale growth exclud impact exchang total abbott medic
devic also includ prior year result stj exclud result amo stj vascular closur
busi compar oper sale growth also reflect reduct st jude medic histor sale
dollar million except per share data
good sold
research develop expens
revenu
consensu incom statement item includ contributor factset
cardiovascular neuromodul
cardiovascular neuromodul intern
total cardiovascular neuromodul
consensu division revenu item includ contributor visibl alpha
consensu estim
compani report leerink partner estim factset visibl alpha
